Use of a new global indicator for vaccine safety surveillance and trends in adverse events following immunization reporting 2000–2015
Reporting of adverse events following immunization (AEFI) is a key component for functional vaccine safety monitoring system. The aim of this study is to document trends in the AEFI reporting ratio globally and across the six World Health Organization (WHO) regions.
’Mise à jour complète du chapitre du Guide canadien d’immunisation : août 2018.
Fournit une liste de vaccins à considérer, pour les adultes.
Although vaccination uptake is high in most countries, pockets of sub-optimal coverage remain, posing a threat to individual and population immunity. Increasingly, the term ‘vaccine hesitancy’ is being used by experts and commentators to explain sub-optimal vaccination coverage. The authors contend that using this term to explain all partial or non-immunization risks generating solutions that are a poor match for the problem in a particular community or population. The authors propose more precision in the term ‘vaccine hesitancy’ is needed, particularly since much under-vaccination arises from factors related to access or pragmatics.
The Canadian Paediatric Society continues to encourage annual influenza vaccination for all children and youth ≥6 months of age. Recommendations from the National Advisory Committee on Immunization (NACI) for the 2017/2018 influenza season are not substantially changed from those of last season. NACI has conducted a review of all available vaccine effectiveness data concerning live attenuated influenza vaccine (LAIV) and concludes that current evidence supports the continued use of LAIV in Canada, although use is not currently recommended in the USA because of concern about efficacy.
Vaccine recommendations for children and youth for the 2018/2019 influenza season: CPS Practice Point
The Canadian Paediatric Society continues to encourage annual influenza vaccination for all children and youth ≥6 months of age. Recommendations from the National Advisory Committee on Immunization (NACI) for the 2018/2019 influenza season are not substantially changed from those of last season. Quadrivalent vaccine, if available, is recommended for children 6 months to 17 years of age. Either inactivated influenza vaccine or live attenuated influenza vaccine may be used for children and youth 2 to 17 years of age who are not immunocompromised.
La présente ressource offre une synthèse des vaccins recommandés aux préadolescents, adolescents et jeunes adultes en bonne santé, âgés de 9 à 25 ans, ayant reçu tous les vaccins recommandés durant l’enfance; on y trouve aussi des conseils à l’intention du personnel soignant.
Most Canadian parents make sure their children are immunized on time, but health care providers often encounter parents who are hesitant about vaccination or refuse recommended vaccines. This practice point offers evidence-based guidance to clinicians on how to work with vaccine-hesitant parents. Steps include: 1) Understanding the health care provider’s key role in parental decision-making and not dismissing vaccine refusers from practice; 2) Using presumptive and motivational interviewing techniques to identify specific vaccine concerns; 3) Using effective, clear language to present evidence for disease risks and vaccine benefits fairly and accurately; 4) Managing pain on immunization; and 5) Reinforcing the importance of and parental responsibility for community protection. Immunization is one of the most important preventive health measures in existence and responsible for saving millions of lives. Addressing the concerns of vaccine-hesitant parents is a priority for health care providers.
The American Academy of Pediatrics (AAP) has assembled a collection of photos of vaccine-preventable diseases to assist journalists reporting on stories on infectious diseases and immunization. Photos may be reprinted to accompany news stories with proper attribution of the source.